Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 50 | 2023 | 212 | 9.670 |
Why?
|
| Melatonin | 41 | 2021 | 90 | 7.520 |
Why?
|
| Sleep | 53 | 2024 | 268 | 6.680 |
Why?
|
| Light | 18 | 2017 | 55 | 3.890 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 18 | 2021 | 46 | 3.570 |
Why?
|
| Sleep Wake Disorders | 12 | 2023 | 107 | 3.220 |
Why?
|
| Phototherapy | 10 | 2019 | 27 | 2.580 |
Why?
|
| Photoperiod | 10 | 2016 | 28 | 2.190 |
Why?
|
| Low Back Pain | 4 | 2020 | 129 | 1.770 |
Why?
|
| Adult | 56 | 2023 | 7031 | 1.600 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2023 | 218 | 1.560 |
Why?
|
| Humans | 87 | 2024 | 23169 | 1.440 |
Why?
|
| Female | 65 | 2023 | 13059 | 1.440 |
Why?
|
| Saliva | 15 | 2018 | 48 | 1.420 |
Why?
|
| Chronic Pain | 4 | 2020 | 126 | 1.380 |
Why?
|
| Lighting | 7 | 2016 | 12 | 1.350 |
Why?
|
| Actigraphy | 7 | 2023 | 80 | 1.270 |
Why?
|
| Male | 51 | 2020 | 12556 | 1.160 |
Why?
|
| Time Factors | 20 | 2018 | 1275 | 1.060 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2018 | 81 | 1.020 |
Why?
|
| Young Adult | 18 | 2020 | 1671 | 0.970 |
Why?
|
| HIV Infections | 4 | 2023 | 424 | 0.920 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2022 | 103 | 0.890 |
Why?
|
| Wrist | 2 | 2022 | 16 | 0.880 |
Why?
|
| Sleep Deprivation | 4 | 2012 | 35 | 0.820 |
Why?
|
| Surveys and Questionnaires | 12 | 2019 | 1037 | 0.800 |
Why?
|
| Affect | 5 | 2020 | 58 | 0.720 |
Why?
|
| Middle Aged | 18 | 2023 | 8000 | 0.700 |
Why?
|
| Chronobiology Disorders | 2 | 2018 | 13 | 0.690 |
Why?
|
| Body Temperature | 9 | 2016 | 40 | 0.680 |
Why?
|
| Psychomotor Performance | 2 | 2012 | 155 | 0.670 |
Why?
|
| Depression | 3 | 2022 | 369 | 0.640 |
Why?
|
| Wakefulness | 11 | 2016 | 68 | 0.630 |
Why?
|
| Receptors, Melatonin | 2 | 2018 | 2 | 0.620 |
Why?
|
| Wearable Electronic Devices | 2 | 2019 | 38 | 0.620 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 70 | 0.590 |
Why?
|
| Hypnotics and Sedatives | 1 | 2018 | 20 | 0.570 |
Why?
|
| Sleep Hygiene | 1 | 2017 | 5 | 0.560 |
Why?
|
| Pain Management | 1 | 2019 | 125 | 0.540 |
Why?
|
| Fibromyalgia | 1 | 2017 | 27 | 0.510 |
Why?
|
| Photic Stimulation | 2 | 2016 | 22 | 0.510 |
Why?
|
| Adolescent | 11 | 2018 | 1916 | 0.510 |
Why?
|
| Housing | 1 | 2016 | 16 | 0.490 |
Why?
|
| Migraine Disorders | 3 | 2022 | 18 | 0.480 |
Why?
|
| Ethanol | 2 | 2016 | 82 | 0.480 |
Why?
|
| Central Nervous System Agents | 1 | 2015 | 7 | 0.480 |
Why?
|
| Chronobiology Phenomena | 1 | 2015 | 3 | 0.480 |
Why?
|
| Jet Lag Syndrome | 5 | 2021 | 11 | 0.470 |
Why?
|
| Acute Pain | 3 | 2020 | 22 | 0.470 |
Why?
|
| Pilot Projects | 5 | 2019 | 378 | 0.460 |
Why?
|
| Wakefulness-Promoting Agents | 1 | 2014 | 1 | 0.450 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 3 | 0.450 |
Why?
|
| Automobile Driving | 1 | 2014 | 17 | 0.440 |
Why?
|
| Occupational Health | 1 | 2014 | 16 | 0.440 |
Why?
|
| Seasons | 1 | 2014 | 19 | 0.440 |
Why?
|
| Motor Skills | 1 | 2014 | 37 | 0.440 |
Why?
|
| Patient Compliance | 2 | 2015 | 145 | 0.440 |
Why?
|
| Catastrophization | 3 | 2019 | 23 | 0.430 |
Why?
|
| Attention | 1 | 2014 | 101 | 0.420 |
Why?
|
| Heart Rate | 4 | 2004 | 104 | 0.410 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2012 | 26 | 0.380 |
Why?
|
| Hypertension | 1 | 2012 | 162 | 0.350 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 33 | 0.340 |
Why?
|
| Polysomnography | 4 | 2022 | 72 | 0.320 |
Why?
|
| Intestinal Mucosa | 3 | 2015 | 155 | 0.310 |
Why?
|
| Activity Cycles | 1 | 2008 | 2 | 0.290 |
Why?
|
| Shift Work Schedule | 2 | 2018 | 7 | 0.280 |
Why?
|
| Pain Threshold | 2 | 2019 | 25 | 0.280 |
Why?
|
| Arousal | 2 | 2005 | 48 | 0.280 |
Why?
|
| Sympathetic Nervous System | 2 | 2005 | 13 | 0.280 |
Why?
|
| Veterans | 2 | 2020 | 86 | 0.280 |
Why?
|
| Heart | 2 | 2005 | 59 | 0.280 |
Why?
|
| tau Proteins | 1 | 2008 | 144 | 0.270 |
Why?
|
| Social Support | 2 | 2018 | 178 | 0.270 |
Why?
|
| Autonomic Nervous System | 2 | 2004 | 19 | 0.260 |
Why?
|
| Quality of Life | 2 | 2022 | 560 | 0.260 |
Why?
|
| Adaptation, Physiological | 2 | 2005 | 42 | 0.250 |
Why?
|
| Self Report | 2 | 2017 | 195 | 0.240 |
Why?
|
| Parasympathetic Nervous System | 1 | 2005 | 2 | 0.240 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2005 | 8 | 0.230 |
Why?
|
| Endotoxemia | 2 | 2015 | 20 | 0.230 |
Why?
|
| Intestinal Absorption | 2 | 2015 | 30 | 0.230 |
Why?
|
| Anxiety | 3 | 2022 | 143 | 0.230 |
Why?
|
| Cell Membrane Permeability | 2 | 2015 | 51 | 0.230 |
Why?
|
| Seasonal Affective Disorder | 1 | 2004 | 1 | 0.220 |
Why?
|
| Cardiography, Impedance | 1 | 2004 | 2 | 0.210 |
Why?
|
| Darkness | 3 | 2010 | 7 | 0.210 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 774 | 0.210 |
Why?
|
| Pain Measurement | 3 | 2020 | 414 | 0.200 |
Why?
|
| Biomarkers | 3 | 2016 | 476 | 0.200 |
Why?
|
| Neurotic Disorders | 1 | 2002 | 14 | 0.200 |
Why?
|
| Critical Care | 1 | 2024 | 110 | 0.200 |
Why?
|
| Kynurenine | 1 | 2022 | 1 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2024 | 247 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 118 | 0.180 |
Why?
|
| Work Schedule Tolerance | 2 | 2016 | 24 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2001 | 52 | 0.180 |
Why?
|
| Volatilization | 1 | 2020 | 4 | 0.170 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 291 | 0.160 |
Why?
|
| Treatment Outcome | 4 | 2020 | 2971 | 0.150 |
Why?
|
| Military Personnel | 1 | 2019 | 37 | 0.150 |
Why?
|
| Drug Administration Schedule | 2 | 2010 | 153 | 0.150 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 2 | 2016 | 8 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2010 | 322 | 0.140 |
Why?
|
| Period Circadian Proteins | 1 | 2018 | 11 | 0.140 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 13 | 0.140 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2016 | 15 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2018 | 79 | 0.140 |
Why?
|
| Urban Population | 1 | 2018 | 132 | 0.140 |
Why?
|
| Specimen Handling | 2 | 2015 | 40 | 0.130 |
Why?
|
| Fluoxetine | 1 | 2017 | 34 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2017 | 88 | 0.130 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 88 | 0.130 |
Why?
|
| Body Mass Index | 3 | 2008 | 382 | 0.130 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 88 | 0.130 |
Why?
|
| United States | 2 | 2019 | 1820 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 29 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2016 | 31 | 0.120 |
Why?
|
| Administration, Oral | 1 | 2016 | 99 | 0.120 |
Why?
|
| Risk Factors | 2 | 2018 | 1988 | 0.120 |
Why?
|
| Colon | 1 | 2016 | 110 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2015 | 51 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 105 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 192 | 0.110 |
Why?
|
| Bacterial Translocation | 1 | 2014 | 19 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 143 | 0.110 |
Why?
|
| Occupations | 1 | 2014 | 13 | 0.110 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 16 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2015 | 234 | 0.110 |
Why?
|
| Sleep Stages | 2 | 2012 | 19 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 243 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 270 | 0.100 |
Why?
|
| Liver | 1 | 2014 | 141 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2023 | 3026 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 592 | 0.100 |
Why?
|
| Biological Clocks | 2 | 2011 | 12 | 0.100 |
Why?
|
| HIV | 2 | 2023 | 39 | 0.100 |
Why?
|
| Sleep, REM | 2 | 2004 | 13 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2004 | 169 | 0.090 |
Why?
|
| Aged | 3 | 2020 | 7498 | 0.090 |
Why?
|
| Cognition | 3 | 2023 | 941 | 0.090 |
Why?
|
| Sex Factors | 2 | 2017 | 389 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2010 | 59 | 0.080 |
Why?
|
| Iris | 1 | 2009 | 2 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 1048 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 382 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2020 | 210 | 0.070 |
Why?
|
| Kinetics | 1 | 2008 | 178 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 167 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 811 | 0.070 |
Why?
|
| Child | 3 | 2015 | 1171 | 0.060 |
Why?
|
| Antioxidants | 1 | 2005 | 56 | 0.060 |
Why?
|
| Permeability | 2 | 2016 | 94 | 0.060 |
Why?
|
| Aviation | 1 | 2005 | 3 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2005 | 76 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 60 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 39 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2003 | 50 | 0.050 |
Why?
|
| Family | 1 | 2024 | 85 | 0.050 |
Why?
|
| Physical Education and Training | 1 | 2003 | 4 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2023 | 16 | 0.050 |
Why?
|
| Rest | 1 | 2003 | 28 | 0.050 |
Why?
|
| Sports | 1 | 2003 | 28 | 0.050 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2022 | 4 | 0.050 |
Why?
|
| Tryptophan | 1 | 2022 | 10 | 0.050 |
Why?
|
| RNA | 1 | 2022 | 31 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 56 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2002 | 6 | 0.050 |
Why?
|
| Overweight | 1 | 2023 | 67 | 0.050 |
Why?
|
| Amygdala | 1 | 2022 | 37 | 0.050 |
Why?
|
| Psychotherapy | 1 | 2022 | 38 | 0.050 |
Why?
|
| Headache | 1 | 2022 | 38 | 0.050 |
Why?
|
| Arrhythmia, Sinus | 1 | 2001 | 2 | 0.050 |
Why?
|
| Respiration | 1 | 2001 | 29 | 0.040 |
Why?
|
| Rectum | 1 | 2001 | 50 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 163 | 0.040 |
Why?
|
| Foot | 1 | 2001 | 40 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2001 | 91 | 0.040 |
Why?
|
| Yoga | 1 | 2020 | 10 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 9 | 0.040 |
Why?
|
| Obesity | 1 | 2023 | 293 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 3754 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 54 | 0.040 |
Why?
|
| Mindfulness | 1 | 2020 | 46 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2019 | 68 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 72 | 0.040 |
Why?
|
| Mice | 2 | 2014 | 1232 | 0.040 |
Why?
|
| Psychology | 1 | 2018 | 15 | 0.040 |
Why?
|
| Psychological Tests | 1 | 2018 | 42 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2018 | 19 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 428 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2020 | 389 | 0.040 |
Why?
|
| Genes | 1 | 2018 | 6 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 7 | 0.040 |
Why?
|
| Emotions | 1 | 2018 | 70 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 47 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 267 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 254 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 166 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 321 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 261 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 58 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 205 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 60 | 0.030 |
Why?
|
| Sleep Medicine Specialty | 1 | 2015 | 3 | 0.030 |
Why?
|
| Chicago | 1 | 2018 | 816 | 0.030 |
Why?
|
| Academies and Institutes | 1 | 2015 | 11 | 0.030 |
Why?
|
| Animals | 2 | 2014 | 3272 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Personality Assessment | 1 | 2015 | 29 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 9 | 0.030 |
Why?
|
| Immunoassay | 1 | 2015 | 35 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 355 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 49 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 87 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 230 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 2014 | 14 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 87 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2014 | 81 | 0.030 |
Why?
|
| Intestines | 1 | 2014 | 76 | 0.030 |
Why?
|
| Cues | 1 | 2013 | 36 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2014 | 578 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 481 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 517 | 0.020 |
Why?
|
| Schools | 1 | 2011 | 37 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 65 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 83 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 1512 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2011 | 38 | 0.020 |
Why?
|
| Circadian Clocks | 1 | 2011 | 20 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 58 | 0.020 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 5 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 17 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 439 | 0.020 |
Why?
|
| MMPI | 1 | 2005 | 3 | 0.010 |
Why?
|
| Time | 1 | 2005 | 14 | 0.010 |
Why?
|
| Personality | 1 | 2005 | 43 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 168 | 0.010 |
Why?
|
| Reaction Time | 1 | 2003 | 78 | 0.010 |
Why?
|
| Pressure | 1 | 2002 | 50 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2002 | 78 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 866 | 0.010 |
Why?
|